Raia Drogasil S.A.
RADLY
$4.48
$0.010.22%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.07B | 1.91B | 1.72B | 1.73B | 1.80B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.07B | 1.91B | 1.72B | 1.73B | 1.80B |
| Cost of Revenue | 1.46B | 1.35B | 1.22B | 1.21B | 1.27B |
| Gross Profit | 608.91M | 564.86M | 492.55M | 511.08M | 535.78M |
| SG&A Expenses | 474.21M | 437.91M | 411.48M | 421.25M | 420.54M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -47.40K | 166.80K | -6.52M | 6.16M | -7.97M |
| Total Operating Expenses | 1.93B | 1.78B | 1.63B | 1.64B | 1.68B |
| Operating Income | 134.75M | 126.78M | 87.59M | 83.66M | 123.21M |
| Income Before Tax | 100.00M | 70.57M | 34.23M | 47.71M | 79.51M |
| Income Tax Expenses | 15.22M | 3.00M | 6.03M | -11.84M | 18.35M |
| Earnings from Continuing Operations | 84.78M | 67.58M | 28.20M | 59.55M | 61.16M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.42M | -1.58M | -190.00K | 20.70K | -739.90K |
| Net Income | 83.37M | 66.00M | 28.01M | 59.57M | 60.42M |
| EBIT | 134.75M | 126.78M | 87.59M | 83.66M | 123.21M |
| EBITDA | 169.17M | 162.56M | 119.67M | 115.04M | 155.52M |
| EPS Basic | 0.05 | 0.04 | 0.02 | 0.04 | 0.04 |
| Normalized Basic EPS | 0.03 | 0.03 | 0.01 | 0.02 | 0.03 |
| EPS Diluted | 0.05 | 0.04 | 0.02 | 0.04 | 0.04 |
| Normalized Diluted EPS | 0.03 | 0.03 | 0.01 | 0.02 | 0.03 |
| Average Basic Shares Outstanding | 1.65B | 1.65B | 1.65B | 1.65B | 1.65B |
| Average Diluted Shares Outstanding | 1.66B | 1.66B | 1.65B | 1.65B | 1.66B |
| Dividend Per Share | 0.02 | 0.01 | 0.01 | -- | 0.02 |
| Payout Ratio | 0.02% | 82.42% | 0.06% | 67.74% | 0.33% |